Keosys-Blog-Graphic-1

The Keosys Blog

Expert insights into medical imaging in clinical trials.
Keosys
HCC Resources
  Hepatocellular Carcinoma (HCC) is the most common cancer of the liver and the..
Keosys
Focus On Selective Internal Radiation Therapy with HCC
This is an excerpt from our free eBook, “Hepatocellular Carcinoma and Imaging..
Keosys
Evaluating Tumor Response in HCC
This is an excerpt from our free eBook, “Hepatocellular Carcinoma and Imaging..
Keosys
An Interventional Radiologist Talks About Radioembolization in the Treatment of HCC Today
Dr. Yan Rolland, head of the diagnosis and interventional radiology department..
Keosys
A Radiology Professor Talks About mRECIST, Reading Images in Clinical Trials, and More
Maxime Ronot, Professor at the Université de Paris, and Radiologist in the..
Keosys
Interview: Keosys Advances into a Promising New Year
With our 20th anniversary year recently completed and a new year underway, we..
Keosys
How to Prepare an Imaging Study While Minimizing Budget and Risk
Sometimes sponsors and CROs are not sure in the early stages of a trial that..
Keosys
Interview: A Medical Doctor Finds Her Biotech Home
We recently spoke with Eveline Boucher, MD, Senior Medical Director for Boston..
Keosys
Keo-Tales: Introducing the Keosys Interns
  Every year, Keosys takes on a select number of interns, giving them the..
Keosys
Central Review According to iRECIST in Cancer Immunotherapy Clinical Trials
This is an excerpt from our free eBook “Imaging and Read Criteria in Cancer..
Keosys
iRECIST and Tumor Response to Immunotherapy with Infographic
iRecist and Tumor Response to Immunotherapy  When immunotherapy is used to..
Keosys
Keo-Tales: Looking Back and Looking Forward
Keosys is an imaging solutions provider supporting biopharmaceutical companies..

More Posts

New call-to-action